Effects of a novel hydrogen sulfide-releasing aspirin (ACS-14) on platelet aggregation

GAO Lin,ZHANG Hui-Li,WANG Chang-Qian,CHENG Chun

2013-01-01

Abstract:AIM To investigate the effects of a novel hydrogen sulfide(H2S) releasing aspirin(ACS14) on platelet aggregation and in comparison to its parent drug,aspirin.METHODS Human platelets were obtained from whole fresh blood drawn from healthy volunteers,then incubated with aspirin,ACS-14 and ACS17 at different concentrations.Thereafter,platelet aggregations,induced by adenosine diphosphate(2.5 μmol.L-1) were monitored by measuring the variation of light transmission.On the other hand,human platelets were incubated with aspirin,ACS-14 and ACS-17(100 μmol.L-1) for different durations,and then their aggregation was assayed.Platelet aggregations induced by thrombin(0.1 U.mL-1) were also detected.RESULTS Pretreatment with ACS-14(10,50,100 and 200 μmol.L-1) for 60 min inhibited ADP-induced platelet aggregation by(63 ± 5) %,(55 ± 6) %,(43 ± 3) %,(37 ± 5) %,respectively(P < 0.05 vs.the control group).After incubated with ACS-14 for 10 min,30 min,60 min and 120 min,percentage of platelet aggregation were(47 ± 4) %,(42 ± 4) %,(45 ± 5) % and(40 ± 5) %,respectively(P < 0.05 vs.the control group).Moreover,the anti-platelet property of ACS-14(≥ 100 μmol.L-1,incubated for 10 min,60 min or 120 min) was more potent than aspirin at the same concentration(P < 0.05).In addition,ACS-14(100 μmol.L-1,60 min) significantly inhibited thrombin-induced platelet aggregation(P < 0.05).CONCLUSION ACS-14 inhibits platelets aggregation in a concentration-dependent manner,and its anti platelet effect is more effective than aspirin.